▶ 調査レポート

世界の硬膜代替品市場2021年ー2031年:材料別(生物学的移植片、合成移植片)、用途別、エンドユーザー別

• 英文タイトル:Dura Substitute Market (Material: Biological Grafts and Synthetic Grafts; Application: Neurosurgery and Spinal Surgery; and End-user: Hospitals, Ambulatory Surgical Center, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Dura Substitute Market (Material: Biological Grafts and Synthetic Grafts; Application: Neurosurgery and Spinal Surgery; and End-user: Hospitals, Ambulatory Surgical Center, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031「世界の硬膜代替品市場2021年ー2031年:材料別(生物学的移植片、合成移植片)、用途別、エンドユーザー別」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2204A067
• 出版社/出版日:Transparency Market Research / 2022年1月
• レポート形態:英文、PDF、339ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Corporate License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査レポートは、世界の硬膜代替品市場について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、材料別(生物学的移植片、合成)分析、用途別分析、エンドユーザー別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを掲載しています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界の硬膜代替品市場規模:材料別(生物学的移植片、合成)
・世界の硬膜代替品市場規模:用途別
・世界の硬膜代替品市場規模:エンドユーザー別
・世界の硬膜代替品市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

Dura Substitute Market – Scope of Report
TMR’s report on the global dura substitute market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global dura substitute market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global dura substitute market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the dura substitute market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global dura substitute market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global dura substitute market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global dura substitute market.

The report delves into the competition landscape of the global dura substitute market. Key players operating in the global dura substitute market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global dura substitute market profiled in this report.

Key Questions Answered in Global Dura Substitute Market Report
What is the sales/revenue generated by dura substitute procedure across all regions during the forecast period?
What are the opportunities in the global dura substitute market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Dura Substitute Market – Research Objectives and Research Approach
The comprehensive report on the global dura substitute market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This allows comparison of the market share of key segments in the past and at the end of the forecast period.

The report analyzes the global dura substitute market in terms of material, application, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global dura substitute market.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Dura Substitute Market
4. Market Overview
4.1. Introduction
4.1.1. Material Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Dura Substitute Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.3. Pricing Analysis
5.4. Product /Brand Analysis, by Application
5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Dura Substitute Market Analysis and Forecast, by Material
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Material, 2017–2031
6.3.1. Biological Grafts
6.3.1.1. Autografts
6.3.1.2. Allografts
6.3.1.3. Xenografts
6.3.1.3.1. Collagen
6.3.1.3.2. Decellularized Pericardium
6.3.1.3.3. Small Intestine Submucosa
6.3.2. Synthetic
6.3.2.1. Polytetrafluoroethylene (PTFE)
6.3.2.2. Others
6.4. Market Attractiveness Analysis, by Material
7. Global Dura Substitute Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Neurosurgery
7.3.2. Spinal Surgery
7.4. Market Attractiveness Analysis, by Application
8. Global Dura Substitute Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Dura Substitute Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Dura Substitute Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Material, 2017–2031
10.2.1. Biological Grafts
10.2.1.1. Autografts
10.2.1.2. Allografts
10.2.1.3. Xenografts
10.2.1.3.1. Collagen
10.2.1.3.2. Decellularized Pericardium
10.2.1.3.3. Small Intestine Submucosa
10.2.2. Synthetic
10.2.2.1. Polytetrafluoroethylene (PTFE)
10.2.2.2. Others
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Neurosurgery
10.3.2. Spinal Surgery
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Material
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. U.S Dura Substitute Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Material, 2017–2031
11.2.1. Biological Grafts
11.2.2. Synthetic
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Neurosurgery
11.3.2. Spinal Surgery
11.4. Market Attractiveness Analysis
11.4.1. By Material
11.4.2. By Application
12. Canada Dura Substitute Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Material, 2017–2031
12.2.1. Biological Grafts
12.2.2. Synthetic
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Neurosurgery
12.3.2. Spinal Surgery
12.4. Market Attractiveness Analysis
12.4.1. By Material
12.4.2. By Application
13. Europe Dura Substitute Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Material, 2017–2031
13.2.1. Biological Grafts
13.2.1.1. Autografts
13.2.1.2. Allografts
13.2.1.3. Xenografts
13.2.1.3.1. Collagen
13.2.1.3.2. Decellularized Pericardium
13.2.1.3.3. Small Intestine Submucosa
13.2.2. Synthetic
13.2.2.1. Polytetrafluoroethylene (PTFE)
13.2.2.2. Others
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Neurosurgery
13.3.2. Spinal Surgery
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Germany
13.5.2. U.K
13.5.3. France
13.5.4. Italy
13.5.5. Spain
13.5.6. Denmark
13.5.7. Sweden
13.5.8. Finland
13.5.9. Iceland
13.5.10. Norway
13.5.11. Rest of Europe
13.6. Market Attractiveness Analysis
13.6.1. By Material
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Germany Dura Substitute Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Material, 2017–2031
14.2.1. Biological Grafts
14.2.2. Synthetic
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Neurosurgery
14.3.2. Spinal Surgery
14.4. Market Attractiveness Analysis
14.4.1. By Material
14.4.2. By Application
15. U.K Dura Substitute Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Material, 2017–2031
15.2.1. Biological Grafts
15.2.2. Synthetic
15.3. Market Value Forecast, by Application, 2017–2031
15.3.1. Neurosurgery
15.3.2. Spinal Surgery
15.4. Market Attractiveness Analysis
15.4.1. By Material
15.4.2. By Application
16. France Dura Substitute Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Material, 2017–2031
16.2.1. Biological Grafts
16.2.2. Synthetic
16.3. Market Value Forecast, by Application, 2017–2031
16.3.1. Neurosurgery
16.3.2. Spinal Surgery
16.4. Market Attractiveness Analysis
16.4.1. By Material
16.4.2. By Application
17. Italy Dura Substitute Market Analysis and Forecast
17.1. Introduction
17.1.1. Key Findings
17.2. Market Value Forecast, by Material, 2017–2031
17.2.1. Biological Grafts
17.2.2. Synthetic
17.3. Market Value Forecast, by Application, 2017–2031
17.3.1. Neurosurgery
17.3.2. Spinal Surgery
17.4. Market Attractiveness Analysis
17.4.1. By Material
18. Competition Landscape
18.1. Market Player – Competition Matrix (by tier and size of companies)
18.2. Market Share Analysis, by Company, 2020
18.3. Company Profiles
18.3.1. Cook Medical LLC
18.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.1.2. Product Portfolio
18.3.1.3. SWOT Analysis
18.3.1.4. Strategic Overview
18.3.2. B. Braun Melsungen AG
18.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.2.2. Product Portfolio
18.3.2.3. SWOT Analysis
18.3.2.4. Strategic Overview
18.3.3. Integra LifeSciences
18.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.3.2. Product Portfolio
18.3.3.3. SWOT Analysis
18.3.3.4. Strategic Overview
18.3.4. Cousin Surgery
18.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.4.2. Product Portfolio
18.3.4.3. SWOT Analysis
18.3.4.4. Strategic Overview
18.3.5. W. L. Gore & Associates, Inc.
18.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.5.2. Product Portfolio
18.3.5.3. SWOT Analysis
18.3.5.4. Strategic Overview
18.3.6. Biosynth Lifesciences
18.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.6.2. Product Portfolio
18.3.6.3. SWOT Analysis
18.3.6.4. Strategic Overview
18.3.7. Acera Surgical, Inc.
18.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.7.2. Product Portfolio
18.3.7.3. SWOT Analysis
18.3.7.4. Strategic Overview
18.3.8. Medprin
18.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.8.2. Product Portfolio
18.3.8.3. SWOT Analysis
18.3.8.4. Strategic Overview
18.3.9. Medtronic
18.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.9.2. Product Portfolio
18.3.9.3. SWOT Analysis
18.3.9.4. Strategic Overview
18.3.10. Stryker
18.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.10.2. Product Portfolio
18.3.10.3. SWOT Analysis
18.3.10.4. Strategic Overview
18.3.11. DePuy Synthes
18.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.11.2. Product Portfolio
18.3.11.3. SWOT Analysis
18.3.11.4. Strategic Overview
18.3.12. Gunze Limited
18.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.12.2. Product Portfolio
18.3.12.3. SWOT Analysis
18.3.12.4. Strategic Overview
18.3.13. Baxter
18.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.13.2. Product Portfolio
18.3.13.3. SWOT Analysis
18.3.13.4. Strategic Overview
18.3.14. Bennett Health, Inc.
18.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.14.2. Product Portfolio
18.3.14.3. SWOT Analysis
18.3.14.4. Strategic Overview
18.3.15. RTI Surgical
18.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.15.2. Product Portfolio
18.3.15.3. SWOT Analysis
18.3.15.4. Strategic Overview
18.3.16. Natus Medical Incorporated
18.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.16.2. Product Portfolio
18.3.16.3. SWOT Analysis
18.3.16.4. Strategic Overview

List of Tables

Table 01: Global Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 02: Global Dura Substitute Market Value (US$ Mn) Forecast, by Biological Grafts, 2017–2031

Table 03: Global Dura Substitute Market Value (US$ Mn) Forecast, by Xenografts, 2017–2031

Table 04: Global Dura Substitute Market Value (US$ Mn) Forecast, by Synthetic, 2017–2031

Table 05: Global Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 06: Global Dura Substitute Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 07: Global Dura Substitute Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 08: North America Dura Substitute Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 09: North America Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 10: North America Dura Substitute Market Value (US$ Mn) Forecast, by Biological Grafts, 2017–2031

Table 11: North America Dura Substitute Market Value (US$ Mn) Forecast, by Xenografts, 2017–2031

Table 12: North America Dura Substitute Market Value (US$ Mn) Forecast, by Synthetic, 2017–2031

Table 13: North America Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 14: North America Dura Substitute Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 15: U.S Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 16: U.S Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 17: Canada Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 18: Canada Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 19: Europe Dura Substitute Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 20: Europe Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 21: Europe Dura Substitute Market Value (US$ Mn) Forecast, by Biological Grafts, 2017–2031

Table 22: Europe Dura Substitute Market Value (US$ Mn) Forecast, by Xenografts, 2017–2031

Table 23: Europe Dura Substitute Market Value (US$ Mn) Forecast, by Synthetic, 2017–2031

Table 24: Europe Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 25: Europe Dura Substitute Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 26: Germany Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 27: Germany Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 28: U.K. Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 29: U.K Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 30: France Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 31: France Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 32: Spain Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 33: Spain Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 34: Italy Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 35: Italy Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 36: Denmark Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 37: Denmark Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 38: Sweden Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 39: Sweden Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 40: Finland Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 41: Finland Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 42: Iceland Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 43: Iceland Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 44: Norway Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 45: Norway Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 46: Rest of Europe Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 47: Rest of Europe Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 48: Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 49: Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 50: Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast, by Biological Grafts, 2017–2031

Table 51: Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast, by Xenografts, 2017–2031

Table 52: Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast, by Synthetic, 2017–2031

Table 53: Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 54: Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 55: China Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 56: China Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 57: Japan Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 58: Japan Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 59: India Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 60: India Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 61: South Korea Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 62: South Korea Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 63: Australia Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 64: Australia Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 65: Rest of Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 66: Rest of Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 67: Latin America Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 68: Latin America Dura Substitute Market Value (US$ Mn) Forecast, by Biological Grafts, 2017–2031

Table 69: Latin America Dura Substitute Market Value (US$ Mn) Forecast, by Xenografts, 2017–2031

Table 70: Latin America Dura Substitute Market Value (US$ Mn) Forecast, by Synthetic, 2017–2031

Table 71: Latin America Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 72: Latin America Dura Substitute Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 73: Middle East & Africa Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 74: Middle East & Africa Dura Substitute Market Value (US$ Mn) Forecast, by Biological Grafts, 2017–2031

Table 75: Middle East & Africa Dura Substitute Market Value (US$ Mn) Forecast, by Xenografts, 2017–2031

Table 76: Middle East & Africa Dura Substitute Market Value (US$ Mn) Forecast, by Synthetic, 2017–2031

Table 77: Middle East & Africa Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 78: Middle East & Africa Dura Substitute Market Value (US$ Mn) Forecast, by End-user, 2017–2031